226 related articles for article (PubMed ID: 23098689)
21. Antiproliferative signalling by 1,25(OH)2D3 in prostate and breast cancer is suppressed by a mechanism involving histone deacetylation.
Banwell CM; Singh R; Stewart PM; Uskokovic MR; Campbell MJ
Recent Results Cancer Res; 2003; 164():83-98. PubMed ID: 12899515
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness.
Ting HJ; Bao BY; Reeder JE; Messing EM; Lee YF
Mol Cancer Res; 2007 Sep; 5(9):967-80. PubMed ID: 17855664
[TBL] [Abstract][Full Text] [Related]
23. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
24. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
25. Biochemical characterization of nuclear receptors for vitamin D3 and glucocorticoids in prostate stroma cell microenvironment.
Hidalgo AA; Montecinos VP; Paredes R; Godoy AS; McNerney EM; Tovar H; Pantoja D; Johnson C; Trump D; Onate SA
Biochem Biophys Res Commun; 2011 Aug; 412(1):13-9. PubMed ID: 21763285
[TBL] [Abstract][Full Text] [Related]
26. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic repression of transcription by the Vitamin D3 receptor in prostate cancer cells.
Gommersall LM; Khanim FL; Peehl DM; Doherty AH; Campbell MJ
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):251-6. PubMed ID: 15225780
[TBL] [Abstract][Full Text] [Related]
28. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
29. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
30. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
[TBL] [Abstract][Full Text] [Related]
31. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor.
Saramäki A; Banwell CM; Campbell MJ; Carlberg C
Nucleic Acids Res; 2006; 34(2):543-54. PubMed ID: 16434701
[TBL] [Abstract][Full Text] [Related]
32. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription.
Zella LA; Meyer MB; Nerenz RD; Lee SM; Martowicz ML; Pike JW
Mol Endocrinol; 2010 Jan; 24(1):128-47. PubMed ID: 19897601
[TBL] [Abstract][Full Text] [Related]
33. Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor.
Kim JY; Son YL; Lee YC
Mol Endocrinol; 2009 Feb; 23(2):251-64. PubMed ID: 19098224
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE.
Sepulveda VA; Weigel NL; Falzon M
Steroids; 2006 Feb; 71(2):102-15. PubMed ID: 16243370
[TBL] [Abstract][Full Text] [Related]
35. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
36. Resistance of HBL100 human breast epithelial cells to vitamin D action.
Agadir A; Lazzaro G; Zheng Y; Zhang XK; Mehta R
Carcinogenesis; 1999 Apr; 20(4):577-82. PubMed ID: 10223184
[TBL] [Abstract][Full Text] [Related]
37. Without 1α-hydroxylation, the gene expression profile of 25(OH)D
Susa T; Iizuka M; Okinaga H; Tamamori-Adachi M; Okazaki T
Sci Rep; 2018 Jun; 8(1):9024. PubMed ID: 29899561
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D receptor expression is required for growth modulation by 1 alpha,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31.
Hedlund TE; Moffatt KA; Miller GJ
J Steroid Biochem Mol Biol; 1996 Jun; 58(3):277-88. PubMed ID: 8836163
[TBL] [Abstract][Full Text] [Related]
39. Non-classical mechanisms of transcriptional regulation by the vitamin D receptor: insights into calcium homeostasis, immune system regulation and cancer chemoprevention.
Dimitrov V; Salehi-Tabar R; An BS; White JH
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():74-80. PubMed ID: 23911725
[TBL] [Abstract][Full Text] [Related]
40. Alternative splicing of the vitamin D receptor modulates target gene expression and promotes ligand-independent functions.
Annalora AJ; Jozic M; Marcus CB; Iversen PL
Toxicol Appl Pharmacol; 2019 Feb; 364():55-67. PubMed ID: 30552932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
